Which medication is commonly administered for clients exhibiting symptoms of depression and suicidal ideation?

Which medication is commonly administered for clients exhibiting symptoms of depression and suicidal ideation?

• A. Sertraline
• B. Fluoxetine
• C. Bupropion
• D. Duloxetine

Answer: (C)

While Bupropion is sometimes used to treat depression, particularly in patients who may not tolerate other antidepressants due to side effects, the more commonly prescribed medications for clients exhibiting symptoms of depression and suicidal ideation are usually sertraline and fluoxetine. Both of these medications belong to the class of selective serotonin reuptake inhibitors (SSRIs), which are often the first-line treatment for major depressive disorder and can help reduce symptoms of both depression and suicidal thoughts. In the context of prioritizing the management of suicidality and depressive symptoms, sertraline and fluoxetine are more frequently utilized than bupropion, which carries a risk of seizures, particularly in certain populations or at higher doses. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is also effective but may not be the first choice compared to the SSRIs in these urgent situations. Overall, the preference for SSRIs like sertraline or fluoxetine in treating depression with suicidal ideation stems from their proven efficacy, safety profile, and the extensive clinical experience supporting their use in managing these serious symptoms.

While Bupropion is sometimes used to treat depression, particularly in patients who may not tolerate other antidepressants due to side effects, the more commonly prescribed medications for clients exhibiting symptoms of depression and suicidal ideation are usually sertraline and fluoxetine. Both of these medications belong to the class of selective serotonin reuptake inhibitors (SSRIs), which are often the first-line treatment for major depressive disorder and can help reduce symptoms of both depression and suicidal thoughts.

In the context of prioritizing the management of suicidality and depressive symptoms, sertraline and fluoxetine are more frequently utilized than bupropion, which carries a risk of seizures, particularly in certain populations or at higher doses. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is also effective but may not be the first choice compared to the SSRIs in these urgent situations.

Overall, the preference for SSRIs like sertraline or fluoxetine in treating depression with suicidal ideation stems from their proven efficacy, safety profile, and the extensive clinical experience supporting their use in managing these serious symptoms.